Endo Pharmaceuticals Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 3,397
Employees
  • Stock Symbol
  • ENDP
Stock Symbol
  • Investments
  • 22
  • Share Price
  • $3.21
  • (As of Friday Closing)

Endo Pharmaceuticals General Information

Description

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL. The majority of its revenue comes from the United States.

Contact Information

Website
www.endo.com
Formerly Known As
Endo Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • First Floor, Minerva House
  • Simmonscourt Road, Ballsbridge
  • Dublin
  • Ireland
+353 (01) 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Endo Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.21 $3.32 $1.94 - $10.89 $750M 234M 6.55M $0.30

Endo Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 7,532,087 8,345,933 7,997,931 8,781,594
Revenue 2,963,998 2,903,074 2,914,364 2,947,078
EBITDA 1,024,640 1,025,228 806,692 306,531
Net Income 68,160 183,944 (422,636) (1,031,469)
Total Assets 9,246,552 9,264,637 9,389,527 10,132,393
Total Debt 8,320,395 8,364,473 8,453,111 8,258,419
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Endo Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Endo Pharmaceuticals‘s full profile, request access.

Request a free trial

Endo Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, o
Pharmaceuticals
Dublin, Ireland
3,397 As of 2020
000.00
000000&0

00000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
000000000000000
Hyderabad, India
00000 As of 0000
00000
000000000 00000

0000 000

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
000000000000000
Petach Tikva, Israel
00000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Endo Pharmaceuticals Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aurobindo Pharma Corporation Hyderabad, India 00000 00000 000000000 00000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Endo Pharmaceuticals Patents

Endo Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2905721-A1 Urethral anastomosis device Abandoned 14-Mar-2013 000000000
AU-2014241104-B2 Urethral anastomosis device Ceased 14-Mar-2013 000000000
AU-2014241104-A1 Urethral anastomosis device Granted 14-Mar-2013 000000000
US-20160074041-A1 Urethral anastomosis device and method Abandoned 14-Mar-2013 000000000 0
EP-2967556-A1 Urethral anastomosis device Withdrawn 14-Mar-2013 A61B17/11
To view Endo Pharmaceuticals’s complete patent history, request access »

Endo Pharmaceuticals Executive Team (31)

Name Title Board Seat Contact Info
Blaise Coleman Chief Executive Officer & Board Member
Patrick Barry Executive Vice President & President, Global Commercial Operations
Mark Bradley Executive Vice President & Chief Financial Officer
Jack Boyle Chief Accounting Officer, Accounting & Controller, Finance
Susan Williamson Senior Vice President & Chief Compliance Officer
You’re viewing 5 of 31 executive team members. Get the full list »

Endo Pharmaceuticals Board Members (16)

Name Representing Role Since
000000 0000000 Endo Pharmaceuticals Board Member 000 0000
000000 0000000 Endo Pharmaceuticals Chief Executive Officer & Board Member 000 0000
00000000 00000 Self Board Member 000 0000
00000000 0000 Endo Pharmaceuticals Board Member 000 0000
0000 00000000 Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Endo Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endo Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Endo Pharmaceuticals‘s full profile, request access.

Request a free trial

Endo Pharmaceuticals Investments & Acquisitions (22)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 01-Dec-2020 0000000000 00000 Pharmaceuticals 000000 00
00000000 0000 26-Apr-2018 0000000000 00000 Pharmaceuticals 0000 0000
00000 0000000 01-Oct-2015 0000000000 00000 Medical Supplies
000 000000000 25-Sep-2015 0000000000 00.000 Pharmaceuticals
Auxilium Pharmaceuticals 29-Jan-2015 Merger/Acquisition 00.000 Pharmaceuticals
You’re viewing 5 of 22 investments and acquisitions. Get the full list »

Endo Pharmaceuticals Subsidiaries (4)

Company Name Industry Location Founded
Somerset Therapeutics Pharmaceuticals Somerset, NJ 2015
00000000 000000000 Pharmaceuticals Chesterbrook, PA 0000
0000000 0000 Pharmaceuticals Saint-Laurent, Canada 0000
000 00000000000000 Pharmaceuticals Ramapo, NY 0000
To view Endo Pharmaceuticals’s complete subsidiaries history, request access »

Endo Pharmaceuticals Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 24-Jul-2014 000000000000000000 00000 Completed
  • 0000 0000000000000
0000000000000 15-Jul-2010 000000000000000000 00000 Completed
  • 0000 0000000000000
Endo Pharmaceuticals Solutions 05-Jan-2009 Merger/Acquisition 00000 Completed
You’re viewing 3 of 4 exits. Get the full list »